Seeking Alpha
 

CVS Health Corporation (CVS)

- NYSE
  • Tue, Mar. 31, 8:46 AM
    • CVS Health (NYSE:CVS) announces new affiliations with medical centers in Illinois and Arizona.
    • The company signed a clinical deal with Rush University Medical Center in Chicago and Tucson Medical Center in Tucson.
    • CVS says it now has more than 50 major health systems and providers in its system.
    | 9 Comments
  • Wed, Mar. 4, 10:48 AM
    • CVS Caremark (NYSE:CVS) declares $0.35/share quarterly dividend, in line with previous.
    • Forward yield 1.36%
    • Payable May 4; for shareholders of record April 24; ex-div April 22.
    | Comment!
  • Thu, Feb. 12, 9:43 AM
    | 3 Comments
  • Wed, Feb. 11, 9:30 AM
    • Investment firms are resetting expectations on CVS Health (NYSE:CVS) after taking in the drugstore chain's Q4 report.
    • Argus raises its price target on CVS to $114 from $104.
    • RBC Capital increases its PT to $115 from $108.
    • Mizuho is also erasing its PT, moving it to $113 from $103.
    • Previously: Margins improve at CVS Health in Q4 (Feb. 10 2015)
    • CVS -0.2% premarket to $101.45.
    | 5 Comments
  • Tue, Feb. 10, 7:18 AM
    • CVS Caremark (NYSE:CVS) reports revenue in its pharmacy segment rose 21.7% to $23.9B in Q4 with acquisition playing a factor.
    • Pharmacy network claims processed rose 8.2% to 221.6M during the period.
    • Retail pharmacy sales +2.9% to $17.7B.
    • Retail comparable-store sales +1.6% with the front end store comp dragged down by the tobacco exit.
    • Gross profit rate +70 bps to 31.4%.
    • Operating profit rate +40 bps to 10.1%.
    • CVS +1.85% premarket.
    | Comment!
  • Tue, Feb. 10, 7:04 AM
    • CVS Caremark (NYSE:CVS): Q4 EPS of $1.21 beats by $0.01.
    • Revenue of $37.06B (+12.9% Y/Y) beats by $980M.
    • Press Release
    | Comment!
  • Mon, Feb. 9, 5:30 PM
  • Thu, Feb. 5, 1:36 PM
    • CVS Health (CVS -0.3%) says its pharmacists have counseled over 67K patients about their smoking habits since pulling out of the category last September.
    • Prescriptions for smoke cessation products are up 63% during the period.
    • Sales of nicotine replacement therapy products are up 21%.
    • Shares of CVS are up 22% since the company's tobacco exit.
    | 15 Comments
  • Wed, Jan. 28, 8:40 AM
    • CVS Health (NYSE:CVS) announces new affiliations with regional health care systems in Kansas and Louisiana.
    • The agreements will increase the scope of medical services provided at CVS stores in the two states.
    • Front-end comps at CVS are still impacted by the full tobacco exit, but are seeing a benefit from the influx of new healthcare customers.
    | 4 Comments
  • Fri, Jan. 23, 8:34 AM
    • CVS Health (NYSE:CVS) could be the buyer of Dollar Tree and Family Dollar stores which need to be divested as part of the mega-discounter merger, speculates Belus Capital Advisors.
    • The company's store count at the end of Q3 was 7,935 spread across 47 U.S. states, Brazil, and Puerto Rico.
    | 6 Comments
  • Wed, Jan. 21, 8:31 AM
    • Stephens initiates coverage on CVS Health (NYSE:CVS) with an Overweight rating.
    • The company also landed an upgrade from Goldman Sachs to Buy from Neutral and price target boost to $113.
    • The general consensus on CVS is that there is more upside for pharmacy sales and that store traffic trends have improved in January.
    | 3 Comments
  • Tue, Jan. 20, 10:56 AM
    • The Supreme Court passes on hearing a case over the level of swipe fees charged by banks to retailers.
    • The cap on swipe fees will stand at $0.21-$0.24 following the high court decision.
    • Intense lobbying from the financial services industry prompted the Fed to move off its original recommendation for a $0.12 cap.
    • The National Retail Federation and other consumer groups have vowed to keep the fight going.
    • Related stocks: V, MA, WMT, TGT, BBY, CVS, WBA, COST, HD, LOW, GPS, M.
    | 10 Comments
  • Wed, Jan. 14, 7:32 AM
    • Shares of CVS Health (NYSE:CVS) are on watch after the stock was recommended on CNBC's Fast Money program.
    • Karen Finerman sees a quick move to $100 for CVS as investors buy into the company's strong underlying growth story.
    • CVS has never cracked the $100 level.
    • Also leaning to the bullish side, SA contributor Jeroen Jongbloed thinks CVS has room to lift its dividend payout even higher.
    | 8 Comments
  • Sun, Jan. 11, 10:44 AM
    • The better-than-expected round of reports on holiday sales in the retail sector has improved the outlook on the profitability of chain stores, according to RetailDive.
    • Teen Retailers: Out with dark lighting and logo-centric marketing and in with fast-fashion and online fulfillment. American Eagle Outfitters (NYSE:AEO), Aeropostale (NYSE:ARO), and Abercrombie & Fitch (NYSE:ANF) are finally pulling the right levers, according to analysts. Deb's Shops, Delia's, and possibly Wet Seal (NASDAQ:WTSL) won't be around to make the transition. It's Hail Mary time at American Apparel (NYSEMKT:APP).
    • Department stores/specialty apparel: Smaller store counts and restructuring initiatives could be the theme in 2015 as mall traffic stays weak. RetailDive doesn't discount turnarounds at Sears Holdings (NASDAQ:SHLD) and J.C. Penney (NYSE:JCP). Gap (NYSE:GPS), Macy's (NYSE:M), and Urban Outfitters (NASDAQ:URBN) are viewed as ahead of the curve in setting their new agenda in place. Soft early comp compares and lower cotton prices could help lift Zumiez (NASDAQ:ZUMZ), Ann (NYSE:ANN), L Brands (NYSE:LB), Pacific Sunwear (NASDAQ:PSUN), and Express (NYSE:EXPR).
    • Drugstores 2.0: Significant changes in the sector have given Walgreen Boots Alliance (NASDAQ:WBA), CVS Health (NYSE:CVS), and Rite Aid (NYSE:RAD) the room to grab more market share in healthcare and grocery. A much worse flu season in the U.S. than a year ago has helped the group get off to a good start.
    • Previously: Holiday retail sales something of a revelation (Jan. 8)
    | 10 Comments
  • Mon, Jan. 5, 12:57 PM
    • CVS Health (CVS -1.3%) bestows Preferred Status to Gilead Sciences' (GILD +2.3%) Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) for the treatment of HCV infection. The pills will be the exclusive treatment option for beneficiaries on CVS's Medicare, Medicaid and other drug benefit plans. AbbVie's (ABBV -2.9%) Viekira Pak will be available only via a medical exception or prior authorization. Recently, AbbVie announced a similar deal with Express Scripts.
    • Previously: AbbVie's new hepatitis C drug gets boost (Dec. 22, 2014)
    | 104 Comments
  • Dec. 20, 2014, 10:17 AM
    • The S&P Retail ETF (NYSEARCA:XRT) is up 3.4% over the last month to outpace the S&P 500 Index as consumer spending trends improve. Analysts have honed in on some categories which show some promise for growth.
    • Drugstores: The transition by the sector into more health/wellness services sets it up for new growth channels. CVS Health (NYSE:CVS) reported strong comparable-store sales despite the full tobacco exit, while Rite Aid (NYSE:RAD) is prepping for a roll-out of RediClinics and HealthSpot kiosks. The visibility on Walgreen (NYSE:WAG) is somewhat clouded by the giant Alliance Boots integration, although it's ahead of rivals on the tech front with its rewards program, pharmacy app and developing online doctor concept.
    • Athleisure: There's some gender initiatives going on in the athletic apparel sector with Under Armour (NYSE:UA) and Nike (NYSE:NKE) growing their women's business and Lululemon (NASDAQ:LULU) expanding on the men's side. All three companies have been closely on-trend with their assortment in a category with explosive demand. Importantly, pricing has held up this holiday season in the U.S., note retail watchers.
    • Online replenishing: Fresh research into shopping trends indicates certain categories see continued buying through the online channel as consumers become attuned to a brand. Retailers positioned well to see more gains from the trend include Williams-Sonoma (NYSE:WSM), Ulta Beauty (NASDAQ:ULTA), Staples (NASDAQ:SPLS), Office Depot (NASDAQ:ODP), Sephora (OTCPK:LVMHF), Dick's Sporting Goods (NYSE:DKS), and of course Amazon (NASDAQ:AMZN).
    • P-E buyouts: There are plenty of candidates in the retail sector for a leveraged buyout similar to the action that helped propel shares of PetSmart (NASDAQ:PETM) +40% from their lows. Keep an eye on Abercrombie & Fitch (NYSE:ANF), Aeropostale (NYSE:ARO), and Ann (NYSE:ANN).
    | Comment!
Visit Seeking Alpha's
CVS vs. ETF Alternatives
Company Description
CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.
Sector: Services
Industry: Drug Stores
Country: United States